-+ 0.00%
-+ 0.00%
-+ 0.00%

West Pharmaceutical Servs Lowers FY2025 GAAP EPS Guidance from $5.97-$6.17 to $5.86-$6.06 vs $6.03 Est

Benzinga·04/24/2025 10:09:11
Listen to the news
West Pharmaceutical Servs (NYSE:WST) lowers FY2025 GAAP EPS guidance from $5.97-$6.17 to $5.86-$6.06 vs $6.03 analyst estimate..